Stereotaxis
12
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
41.7%
5 terminated/withdrawn out of 12 trials
54.5%
-32.0% vs industry average
33%
4 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The MAGiC™ Cardiac Ablation European Study
Role: lead
RMN Versus Manual Epicardial Retrospective PMCF
Role: lead
Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population
Role: lead
Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia
Role: lead
Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study
Role: lead
Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study
Role: lead
Pulmonary Vein Ablation of Atrial Fibrillation Using Magnetic Navigation: Single Ring Versus Circumferential Techniques
Role: collaborator
PowerAssert Radio-Frequency (RF) Guidewire Coronary In-Stent Chronic Total Occlusion (CTO)
Role: lead
Stereotaxis Computed Tomography (CT) Co-Registration Study
Role: lead
Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation
Role: collaborator
HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study
Role: lead
MAGNET CRT Feasibility - Efficiency of LV Lead Placement Comparing Conventional vs. Magnetic Guidance
Role: lead
All 12 trials loaded